Send this to a friend

Biostage awarded up to $1.7M grant for preclinical study

Funding for Biostage’s bioengineered throat organ implants continues to pile up, as the Holliston company announced Thursday it has been awarded a grant worth up to $1.7 million.
The Fast Track Small Business Innovation Research grant from the federal program Eunice Kennedy National Institute of Child & Human Development, will support the company’s development and preclinical testing of its Cellspan Esophageal Implant for treating p ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media